Spinal Muscular Atrophy Trial, Recruiting (NCT06666816)

Spinal Muscular Atrophy Trial, Recruiting NCT06666816 Sponsor: IRCCS Eugenio Medea Condition: Spinal Muscular Atrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06666816 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Spinal Muscular Atrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult who can walk (even with the help of a walking aid or support) and have been diagnosed through genetic testing with a muscular dystrophy or myopathy (such as a condition affecting the muscles from birth or developing later in life), spinal muscular atrophy (SMA), or Charcot-Marie-Tooth disease type 1 or 2.

Who may not be able to join:

You have a heart condition where the heart muscle is enlarged or has been damaged by reduced blood flow, and this is causing moderate problems with how your heart works.
You have serious long-term breathing difficulties, specifically if your lungs are working at less than 40% of their expected capacity, or if your blood oxygen levels drop too low for more than 5% of the time while you are sleeping.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39031877111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06666816

Sponsor: IRCCS Eugenio Medea

Phase: Not Applicable

Status: Recruiting

Condition: Spinal Muscular Atrophy

Trial contact: +39031877111

More information: https://clinicaltrials.gov/study/NCT06666816

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult who can walk (even with the help of a walking aid or support) and have been diagnosed through genetic testing with a muscular dystrophy or myopathy (such as a condition affecting the muscles from birth or developing later in life), spinal muscular atrophy (SMA), or Charcot-Marie-Tooth disease type 1 or 2.

Who may not be able to join:

You have a heart condition where the heart muscle is enlarged or has been damaged by reduced blood flow, and this is causing moderate problems with how your heart works.
You have serious long-term breathing difficulties, specifically if your lungs are working at less than 40% of their expected capacity, or if your blood oxygen levels drop too low for more than 5% of the time while you are sleeping.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Eugenio Medea

Registry

ClinicalTrials.gov

Start date

27 October 2017

Est. completion

1 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Variation in walking speed during a 6-minutes walking test; Subjective fatigue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov